CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
This Quarter Return
-13.64%
1 Year Return
+37.91%
3 Year Return
+125.34%
5 Year Return
–
10 Year Return
–
AUM
$53.1M
AUM Growth
+$53.1M
(-50%)
Cap. Flow
-$43.4M
Cap. Flow
% of AUM
-81.78%
Top 10 Holdings %
Top 10 Hldgs %
89.08%
Holding
20
New
4
Increased
2
Reduced
7
Closed
7
Top Buys
| 1 |
Gilead Sciences
GILD
|
$6.19M |
| 2 |
Merck
MRK
|
$5.23M |
| 3 |
Illumina
ILMN
|
$3.31M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$2.72M |
| 5 |
AGN
Allergan plc
AGN
|
$2.01M |
Top Sells
| 1 |
DaVita
DVA
|
$12.6M |
| 2 |
Stryker
SYK
|
$7.06M |
| 3 |
NUVA
NuVasive, Inc.
NUVA
|
$6.19M |
| 4 |
Edwards Lifesciences
EW
|
$5.67M |
| 5 |
Amicus Therapeutics
FOLD
|
$5.55M |
Sector Composition
| 1 | Healthcare | 94.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Illumina
ILMN
$15.2B
| $6.25M | 11.76% |
20,828
+11,026
| +112% | +$3.31M |
|
|
2
Gilead Sciences
GILD
$139B
| $6.19M | 11.66% |
+99,000
| New | +$6.19M |
|
3
Intuitive Surgical
ISRG
$167B
| $5.56M | 10.46% |
11,606
-10,275
| -47% | -$4.92M |
|
4
Vertex Pharmaceuticals
VRTX
$101B
| $5.45M | 10.26% |
32,883
-30,024
| -48% | -$4.98M |
|
|
5
Merck
MRK
$212B
| $5.23M | 9.85% |
+68,461
| New | +$5.23M |
|
6
Thermo Fisher Scientific
TMO
$181B
| $4.25M | 8% |
19,000
-1,206
| -6% | -$270K |
|
7
CVS Health
CVS
$94B
| $3.93M | 7.39% |
59,956
-80,053
| -57% | -$5.24M |
|
8
Zoetis
ZTS
$67.4B
| $3.89M | 7.32% |
45,439
-10,021
| -18% | -$857K |
|
|
9
Stryker
SYK
$149B
| $3.86M | 7.27% |
24,626
-45,026
| -65% | -$7.06M |
|
|
WCG
10
DELISTED
Wellcare Health Plans, Inc.
WCG
| $2.72M | 5.11% |
+11,500
| New | +$2.72M |
|
11
Heron Therapeutics
HRTX
$205M
| $2.41M | 4.54% |
93,000
+50,178
| +117% | +$1.3M |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $2.01M | 3.77% |
+15,000
| New | +$2.01M |
|
13
CareDx
CDNA
$735M
| $1.38M | 2.6% |
54,976
-10,024
| -15% | -$252K |
|
|
14
DaVita
DVA
$9.75B
| – | – |
-176,403
| Closed | -$12.6M |
|
15
Elanco Animal Health
ELAN
$8.87B
| – | – |
-51,000
| Closed | -$1.78M |
|
|
16
Edwards Lifesciences
EW
$48B
| – | – |
-32,544
| Closed | -$5.67M |
|
|
17
Amicus Therapeutics
FOLD
$2.39B
| – | – |
-458,630
| Closed | -$5.55M |
|
18
Henry Schein
HSIC
$8.29B
| – | – |
-54,563
| Closed | -$4.64M |
|
|
PDCO
19
DELISTED
Patterson Companies, Inc.
PDCO
| – | – |
-170,000
| Closed | -$4.16M |
|
|
NUVA
20
DELISTED
NuVasive, Inc.
NUVA
| – | – |
-87,205
| Closed | -$6.19M |
|